🇺🇸 Dihydroartemisinin in United States

13 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Electrocardiogram Qt Prolonged — 3 reports (23.08%)
  2. Drug Interaction — 2 reports (15.38%)
  3. Anaemia — 1 report (7.69%)
  4. Cardiotoxicity — 1 report (7.69%)
  5. Cerebrovascular Accident — 1 report (7.69%)
  6. Fall — 1 report (7.69%)
  7. Haematotoxicity — 1 report (7.69%)
  8. Haemolytic Anaemia — 1 report (7.69%)
  9. Hemiplegia — 1 report (7.69%)
  10. Hepatic Enzyme Increased — 1 report (7.69%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Dihydroartemisinin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Dihydroartemisinin in United States?

Shanghai Zhongshan Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.